Steele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P., Upstill-Goddard, R., Rishi, L., . . . Morton, J. P. (2016). CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma. Cancer cell, 29(6), 832. https://doi.org/10.1016/j.ccell.2016.04.014
Citace podle Chicago (17th ed.)Steele, Colin W., et al. "CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma." Cancer Cell 29, no. 6 (2016): 832. https://doi.org/10.1016/j.ccell.2016.04.014.
Citace podle MLA (9th ed.)Steele, Colin W., et al. "CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma." Cancer Cell, vol. 29, no. 6, 2016, p. 832, https://doi.org/10.1016/j.ccell.2016.04.014.